Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.

The MRC UKALL IX trial for patients with untreated ALL aged 14 years and over was open to new patients from July 1980 to April 1985. 266 patients were randomized between two induction schedules. M (involving intermediate dose methotrexate with folinic acid rescue) and D (involving daunorubicin). Sch...

Full description

Bibliographic Details
Main Authors: Durrant, I, Richards, S
Format: Journal article
Language:English
Published: 1993
_version_ 1826271777025687552
author Durrant, I
Richards, S
author_facet Durrant, I
Richards, S
author_sort Durrant, I
collection OXFORD
description The MRC UKALL IX trial for patients with untreated ALL aged 14 years and over was open to new patients from July 1980 to April 1985. 266 patients were randomized between two induction schedules. M (involving intermediate dose methotrexate with folinic acid rescue) and D (involving daunorubicin). Schedule M resembled that used in the previous MRC adult ALL trial (UKALL VI), while schedule D was somewhat more intensive. No difference in disease-free survival was found between the treatment arms, but patients on the daunorubicin arm went into remission earlier. The overall remission rate was 87%, which is at least as good as in contemporary studies elsewhere; factors predictive of a lower remission rate were older age and higher WBC. For those who entered remission. WBC, age and sex were the most important prognostic factors. Time to achieve remission was not a significant factor after allowance was made for these. An historical comparison does not show any improvement over the preceding MRC adult trial, although the subsequent trial does show a modest improvement at present. Because the improved outlook seen in children is not apparent in adults, and no other randomized trial has demonstrated substantial benefit for any particular regimen, the next trial, UKALL XII, will be investigating the benefit or otherwise of bone marrow transplantation.
first_indexed 2024-03-06T22:02:03Z
format Journal article
id oxford-uuid:4eef9f15-7831-4870-9fb1-c072cb5923db
institution University of Oxford
language English
last_indexed 2024-03-06T22:02:03Z
publishDate 1993
record_format dspace
spelling oxford-uuid:4eef9f15-7831-4870-9fb1-c072cb5923db2022-03-26T16:04:06ZResults of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4eef9f15-7831-4870-9fb1-c072cb5923dbEnglishSymplectic Elements at Oxford1993Durrant, IRichards, SThe MRC UKALL IX trial for patients with untreated ALL aged 14 years and over was open to new patients from July 1980 to April 1985. 266 patients were randomized between two induction schedules. M (involving intermediate dose methotrexate with folinic acid rescue) and D (involving daunorubicin). Schedule M resembled that used in the previous MRC adult ALL trial (UKALL VI), while schedule D was somewhat more intensive. No difference in disease-free survival was found between the treatment arms, but patients on the daunorubicin arm went into remission earlier. The overall remission rate was 87%, which is at least as good as in contemporary studies elsewhere; factors predictive of a lower remission rate were older age and higher WBC. For those who entered remission. WBC, age and sex were the most important prognostic factors. Time to achieve remission was not a significant factor after allowance was made for these. An historical comparison does not show any improvement over the preceding MRC adult trial, although the subsequent trial does show a modest improvement at present. Because the improved outlook seen in children is not apparent in adults, and no other randomized trial has demonstrated substantial benefit for any particular regimen, the next trial, UKALL XII, will be investigating the benefit or otherwise of bone marrow transplantation.
spellingShingle Durrant, I
Richards, S
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title_full Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title_fullStr Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title_full_unstemmed Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title_short Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
title_sort results of medical research council trial ukall ix in acute lymphoblastic leukaemia in adults report from the medical research council working party on adult leukaemia
work_keys_str_mv AT durranti resultsofmedicalresearchcounciltrialukallixinacutelymphoblasticleukaemiainadultsreportfromthemedicalresearchcouncilworkingpartyonadultleukaemia
AT richardss resultsofmedicalresearchcounciltrialukallixinacutelymphoblasticleukaemiainadultsreportfromthemedicalresearchcouncilworkingpartyonadultleukaemia